Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Nov 24, 2014; 3(3): 351-357
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.351
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.351
Table 1 Clinicopathological parameters for patients with seminomatous testicular germ cell cancer n (%)
| Variables | Carcinoma (n = 11) | Control (n = 5) |
| Age in years mean (range) | 40.58 (33-53) | 30.75 (24-42) |
| Pathological stage | ||
| pT1 | 7 (63.6) | NA |
| pT2 | 2 (18.2) | NA |
| pT3 | 2 (18.2) | NA |
| Lymphnode metastasis | ||
| cNx | 1 (9.1) | NA |
| cN0 | 7 (63.6) | NA |
| cN1 | 1 (9.1) | NA |
| cN2 | 2 (18.2) | NA |
| M-stage | ||
| cMx | 1 (9.1) | NA |
| cM0 | 10 (90.9) | NA |
| Tumor marker | ||
| HCG increased | 5 (45.5) | NA |
| LDH increased | 3 (45.5) | NA |
| AFP increased | 0 (0) | NA |
| Clinical tumor stage | ||
| CSIA | 5 (45.5) | NA |
| CSIS | 3 (27.3) | NA |
| CSIIB | 1 (9.1) | NA |
| CSIIC | 2 (18.2) | NA |
Table 2 Clinicopathological parameters for patients with non-seminomatous testicular germ cell cancer n (%)
| Variables | Carcinoma (n = 14) | Control (n = 5) |
| Age in years mean (range) | 32.58 (16) | 30.75 (18) |
| Pathological stage | ||
| pT1 | 5 (26.3) | NA |
| pT2 | 5 (26.3) | NA |
| pT3 | 3 (15.8) | NA |
| pTx | 1 (18.2) | NA |
| Lymphnode metastasis | ||
| Nx | 7 (36.8) | NA |
| N0 | 4 (21.1) | NA |
| N3 | 3 (15.8) | NA |
| M-stage | ||
| Mx | 4 (21.1) | NA |
| M0 | 9 (47.7) | NA |
| M1 | 1 (5.3) | NA |
| Tumor markers | ||
| HCG increased | 13 (68.8) | NA |
| LDH increased | 7 (36.8) | NA |
| AFP increased | 12 (85.7) | NA |
| Clinical stage | ||
| IS | 8 (42.1) | NA |
| IIA | 2 (10.5) | NA |
| IIC | 3 (15.8) | NA |
| NA | 1 (5.3) | NA |
Table 3 Clinicopathological parameters for patients with renal tumors n (%)
| Variables | RCC (n = 188) | Normal/oncocytoma (n = 28) |
| Age in years mean (range) | 60.4 (0-85) | 56.86 (26-75) |
| Sex | ||
| Male | 128 (68.1) | 12 (42.9) |
| Female | 60 (31.9) | 16 (57.1) |
| Pathological stage | ||
| pT1 | 81 (37.5) | NA |
| pT2 | 40 (18.5) | NA |
| pT3 | 57 (26.4) | NA |
| pT4 | 3 (1.4) | NA |
| Missing | 7 (16.2) | NA |
| Lymphnode metastasis | ||
| pN0 | 96 (44.4) | NA |
| pN1 | 6 (2.8) | NA |
| pN2 | 9 (4.2) | NA |
| pNx | 72 (33.3) | NA |
| Missing | 5 (15.3) | NA |
| Metastasis | ||
| M0 | 114 (52.8) | NA |
| M1 | 24 (11.1) | NA |
| M2 | 1 (0.5) | NA |
| Mx | 42 (19.4) | NA |
| Missing | 7 (16.2) | NA |
| Grade | ||
| G1 | 56 (25.9) | NA |
| G2 | 111 (51.4) | NA |
| G3 | 12 (5.6) | NA |
| G4 | 2 (0.9) | NA |
| Missing | 7 (16.2) | NA |
Table 4 Clinicopathological parameters for patients with penile carcinoma n (%)
| Variables | Carcinoma (n = 57) | Metastasis (n = 17) | Control (n = 26) |
| Age in years mean (range) | 63.32 (35-93) | 62.96 (11-87) | 64.15 (37-97) |
| Pathological stage | |||
| Cis | 4 (7) | NA | |
| pT1 | 26 (45.6) | NA | |
| pT2 | 15 (26.3) | NA | |
| pT3 | 11 (19.3) | NA | |
| pT4 | 1 (1.8) | NA | |
| Lymph node metastasis | |||
| cN0 | 50 (87.7) | NA | |
| pN+ | 7 (12.3) | NA | |
| M-stage | |||
| cM0 | 57 (100) | NA | |
| Grading | |||
| G1 | 9 (17) | NA | |
| G2 | 36 (67.9) | NA | |
| G3 | 8 (15.1) | NA | |
| Missing | 4 (7) | NA | |
| Surgical margins | |||
| R0 | 55 (79.7) | 10 (58.8) | |
| R1 | 2 (2.9) | 0 (0) | |
| R2 | 0 (0) | 2 (11.8) |
- Citation: Fischer N, Göke F, Kahl P, Splittstößer V, Lankat-Buttgereit B, Müller SC, Ellinger J. Programmed cell death protein 4 expression in renal cell carcinoma, penile carcinoma and testicular germ cell cancer. World J Clin Urol 2014; 3(3): 351-357
- URL: https://www.wjgnet.com/2219-2816/full/v3/i3/351.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.351